Shefali Agarwal

Shefali Agarwal currently works at Sironax Ltd., as President, Chief Executive Officer & Director, Valour Bio SAS, as President & Chief Executive Officer, Fate Therapeutics, Inc., as Independent Director from 2019, ITB-MED AB, as Director, and Valerio Therapeutics SA, as President from 2024.
Dr. Agarwal also formerly worked at Nexoplex Bio, Inc., as Independent Director from 2021 to 2025, TopoTarget UK Ltd., as Director, SQZ Biotechnologies Co., as Chief Medical Officer from 2017 to 2018, and Epizyme, Inc., as Executive VP, Chief Medical & Development Officer from 2021 to 2022.
Dr. Agarwal received her graduate degree in 2003 from The Johns Hopkins University, doctorate degree in 2000 from Karnataka University, and graduate degree in 2002 from Merrick School of Business.